期刊文献+

骨髓增生异常综合征难治性贫血与巨幼细胞贫血细胞形态学比较 被引量:2

The Morphocytologic Comparison of Myelodysplastic Syndronre-refractory(MDS-RA) and Megaloblastic Anemia(MA)
下载PDF
导出
摘要 目的通过对骨髓增生异常综合征--难治性贫血(MDS-RA)和巨幼细胞贫血(MA)进行细胞形态学比较,提高其诊断与鉴别水平。方法对23例MDS-RA与28例MA患者进行常规骨髓穿刺涂片,进行瑞氏染色光学显微镜下观察比较。结果MDS-RA以双核红细胞及奇数核红细胞、淋巴样小巨核最有特征。MA骨髓红系呈明显的“幼核老浆”改变;粒系以中幼粒以下各阶段细胞巨型改变;未发现淋巴杆小巨核细胞。结论淋巴样小巨核细胞是MDS-RA主要特征;MA骨髓细胞呈”幼核老桨”,并以红系为明显。 Objective To improve the level of diagnosis and idehtification diagnosis of MDS-RA by their morphocytologic comparison.Methods The normal bone marrow smears of 23 cases with MDS-RA and 28 cases with MA were stained by Wright's staining,and then observed by optical microscope and compared.Results Odd nucleus,great red cell and lymphoid small macronucleus have great diagnosis value in MDS-RA;`Juvenile nucleus and senile cytolipin'especially in the red series-is the character of MA,while the granule series have a change of megakaryoblast in each stage after myeloayte.No lymphoid small megakaryocyte had been found.Conclusion Lymphoid small megakaryocyte is the main characteristic of MDS-RA;MA had a characteristic of `juvenile nucleus and senile cytolipin',especially in the red series.
作者 苏彤 律洁
出处 《医学检验与临床》 2007年第2期25-26,共2页 Medical Laboratory Science and Clinics
  • 相关文献

同被引文献17

  • 1朱伟,张加强,郭玉琳,张鲁勤.巨幼细胞性贫血误诊为骨髓增生异常综合征[J].临床误诊误治,2005,18(5):307-308. 被引量:4
  • 2吴玲剑,王霄霞.巨幼细胞性贫血与难治性贫血的骨髓病态造血特点分析[J].检验医学教育,2006,13(1):44-46. 被引量:3
  • 3葸瑞,张茜,周进茂.巨幼细胞贫血与骨髓增生异常综合征红细胞形态的比较[J].中国综合临床,2006,22(11):1049-1049. 被引量:2
  • 4曹志红,祝焱,彭敏源.急性白血病LDH及HBDH测定的临床意义[J].实用预防医学,2007,14(2):489-490. 被引量:10
  • 5Macdougall IC,Cooper AC.Erythropoietin resistance:the role ofinflammation and pro-inflammatory cytokines[J].Nephrol DialTransplant,2002,17(Suppl 11):39-43.
  • 6Cui W,Sun J,Cotta CV,et al.Myelodysplastic syndrome with inv(3)(q21q26.2)or t(3;3)(q21;q26.2)has a high risk for pro-gression to acute myeloid leukemia[J].Am J Clin Pathol,2011,136(2):282-288.
  • 7Machado-Neto JA,Traina F,Lazarini M,et al.Screening for hotspotmutations in PI3K,JAK2,FLT3 and NPM1 in patients with myelo-dysplastic syndromes[J].Clinics(Sao Paulo),2011,66(5):793-799.
  • 8Nomdedeu M,Maffioli M,Calvo X,et al.Efficacy of lenalidomide ina patient with myelodysplastic syndrome with isolated del(5q)andJAK2V617F mutation[J].Leuk Res,2011,35(9):1276-1278.
  • 9Bejar R,Stevenson K,Abdel-Wahab O,et al.Clinical effect ofpoint mutations in myelodysplastic syndromes[J].N Engl J Med,2011,364(26):2496-2506.
  • 10Wimazal F,Sperr WR,Kundi M,et al.Prognostic significance ofserial determinations of lactate dehydrogenase(LDH)in the follow-up of patients with myelodysplastic syndromes[J].Ann Oncol,2008,19(5):970-976.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部